Back to News
Market Impact: 0.55
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
Source: Nasdaq
Healthcare & BiotechRegulation & Legislation
The White House added nine drug manufacturers to its most-favored-nation pricing agreements, bringing participation to 26 companies representing 89% of the branded-drug market. Despite drug-pricing policy returning to prominence, healthcare investors have shown limited immediate reaction, suggesting the agreements were broadly anticipated or viewed as manageable for sector earnings.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- Jio’s Record $3.2 Billion IPO Puts India’s Market Muscle to the Test
- A top medical technology stock is trading at a big discount. Here's why I'm buying
- Obsessed with CoreWeave and the AI trade? You're missing out on some great stocks
- UnitedHealthcare and Humana are ending Medicare Advantage plans for nearly 1 million people
- Why is Intuitive Surgical stock sliding today?
- Alpha Teknova stock tumbles on public offering announcement